Bank of New York Mellon
NMRD

Bank of New York Mellon’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Bank of New York Mellon’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,280
Closed -$117K – 4492
2021
Q1 		$117K Hold
15,280
– – ﹤0.01% 4144
2020
Q4 		$57K Sell
15,280
-793
-5% -$3.06K ﹤0.01% 4140
2020
Q3 		$57K Hold
16,073
– – ﹤0.01% 4008
2020
Q2 		$149K Buy
+16,073
New +$115K ﹤0.01% 3862

Other funds holding NMRD

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of New York Mellon's NMRD Position: Q2 2021 in Review

Bank of New York Mellon sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q2 2021, closing a stake of 15,280 shares — an estimated $117K sold.

Bank of New York Mellon first reported a position in NMRD in Q2 2020 and held it in 4 quarters. The position peaked at $149K in Q2 2020. 29 funds tracked by Wall St. Rank hold NMRD as of Q2 2021.

  • Bank of New York Mellon reported no remaining Nemaura Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 15,280 Nemaura Medical, Inc. Common Stock shares in Q2 2021, an estimated $117K.
  • Bank of New York Mellon first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Bank of New York Mellon's Nemaura Medical, Inc. Common Stock position peaked at $149K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.